vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and TRICO BANCSHARES (TCBK). Click either name above to swap in a different company.
TRICO BANCSHARES is the larger business by last-quarter revenue ($109.4M vs $83.1M, roughly 1.3× PROCEPT BioRobotics Corp). TRICO BANCSHARES runs the higher net margin — 251.6% vs -38.1%, a 289.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (20.2% vs 9.0%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 5.4%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
Trico Bancshares is a U.S.-headquartered regional bank holding company operating Tri Counties Bank. It offers a full range of retail and commercial banking services including deposit products, mortgages, small business loans, and wealth management, primarily serving consumers and SMEs in Northern California.
PRCT vs TCBK — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.1M | $109.4M |
| Net Profit | $-31.6M | $33.6M |
| Gross Margin | 64.9% | — |
| Operating Margin | -4.1% | 42.6% |
| Net Margin | -38.1% | 251.6% |
| Revenue YoY | 20.2% | 9.0% |
| Net Profit YoY | -27.9% | 15.8% |
| EPS (diluted) | $-0.56 | $1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $83.1M | — | ||
| Q4 25 | $76.4M | $109.4M | ||
| Q3 25 | $83.3M | $107.6M | ||
| Q2 25 | $79.2M | $103.6M | ||
| Q1 25 | $69.2M | $98.6M | ||
| Q4 24 | $68.2M | $100.4M | ||
| Q3 24 | $58.4M | $99.1M | ||
| Q2 24 | $53.4M | $97.9M |
| Q1 26 | $-31.6M | — | ||
| Q4 25 | $-29.8M | $33.6M | ||
| Q3 25 | $-21.4M | $34.0M | ||
| Q2 25 | $-19.6M | $27.5M | ||
| Q1 25 | $-24.7M | $26.4M | ||
| Q4 24 | $-18.9M | $29.0M | ||
| Q3 24 | $-21.0M | $29.1M | ||
| Q2 24 | $-25.6M | $29.0M |
| Q1 26 | 64.9% | — | ||
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 59.0% | — |
| Q1 26 | -4.1% | — | ||
| Q4 25 | -40.6% | 42.6% | ||
| Q3 25 | -27.8% | 43.2% | ||
| Q2 25 | -28.0% | 36.5% | ||
| Q1 25 | -39.7% | 35.8% | ||
| Q4 24 | -28.9% | 38.7% | ||
| Q3 24 | -38.4% | 39.8% | ||
| Q2 24 | -50.3% | 40.0% |
| Q1 26 | -38.1% | — | ||
| Q4 25 | -39.1% | 251.6% | ||
| Q3 25 | -25.7% | 31.6% | ||
| Q2 25 | -24.7% | 26.6% | ||
| Q1 25 | -35.8% | 26.7% | ||
| Q4 24 | -27.6% | 221.4% | ||
| Q3 24 | -35.9% | 29.3% | ||
| Q2 24 | -48.0% | 29.7% |
| Q1 26 | $-0.56 | — | ||
| Q4 25 | $-0.54 | $1.02 | ||
| Q3 25 | $-0.38 | $1.04 | ||
| Q2 25 | $-0.35 | $0.84 | ||
| Q1 25 | $-0.45 | $0.80 | ||
| Q4 24 | $-0.34 | $0.88 | ||
| Q3 24 | $-0.40 | $0.88 | ||
| Q2 24 | $-0.50 | $0.87 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $245.6M | $157.0M |
| Total DebtLower is stronger | $51.7M | — |
| Stockholders' EquityBook value | $347.7M | $1.3B |
| Total Assets | $487.1M | $9.8B |
| Debt / EquityLower = less leverage | 0.15× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $245.6M | — | ||
| Q4 25 | $286.5M | $157.0M | ||
| Q3 25 | $294.3M | $298.8M | ||
| Q2 25 | $302.7M | $314.3M | ||
| Q1 25 | $316.2M | $308.3M | ||
| Q4 24 | $333.7M | $145.0M | ||
| Q3 24 | $196.8M | $320.1M | ||
| Q2 24 | $214.1M | $206.6M |
| Q1 26 | $51.7M | — | ||
| Q4 25 | $51.6M | — | ||
| Q3 25 | $51.6M | — | ||
| Q2 25 | $51.5M | — | ||
| Q1 25 | $51.5M | — | ||
| Q4 24 | $51.5M | — | ||
| Q3 24 | $51.4M | — | ||
| Q2 24 | $51.4M | — |
| Q1 26 | $347.7M | — | ||
| Q4 25 | $365.9M | $1.3B | ||
| Q3 25 | $380.3M | $1.3B | ||
| Q2 25 | $385.8M | $1.3B | ||
| Q1 25 | $389.2M | $1.3B | ||
| Q4 24 | $402.2M | $1.2B | ||
| Q3 24 | $241.2M | $1.2B | ||
| Q2 24 | $251.8M | $1.2B |
| Q1 26 | $487.1M | — | ||
| Q4 25 | $508.1M | $9.8B | ||
| Q3 25 | $511.5M | $9.9B | ||
| Q2 25 | $513.1M | $9.9B | ||
| Q1 25 | $519.4M | $9.8B | ||
| Q4 24 | $534.0M | $9.7B | ||
| Q3 24 | $374.1M | $9.8B | ||
| Q2 24 | $374.4M | $9.7B |
| Q1 26 | 0.15× | — | ||
| Q4 25 | 0.14× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.13× | — | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $133.3M |
| Free Cash FlowOCF − Capex | — | $127.9M |
| FCF MarginFCF / Revenue | — | 116.9% |
| Capex IntensityCapex / Revenue | — | 4.9% |
| Cash ConversionOCF / Net Profit | — | 3.96× |
| TTM Free Cash FlowTrailing 4 quarters | — | $222.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-10.3M | $133.3M | ||
| Q3 25 | $-6.6M | $45.1M | ||
| Q2 25 | $-15.0M | $29.2M | ||
| Q1 25 | $-17.0M | $24.5M | ||
| Q4 24 | $-32.4M | $109.7M | ||
| Q3 24 | $-18.8M | $28.6M | ||
| Q2 24 | $-15.7M | $31.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-12.2M | $127.9M | ||
| Q3 25 | $-9.5M | $43.2M | ||
| Q2 25 | $-17.8M | $28.2M | ||
| Q1 25 | $-18.8M | $22.8M | ||
| Q4 24 | $-33.6M | $105.2M | ||
| Q3 24 | $-19.0M | $27.3M | ||
| Q2 24 | $-16.8M | $30.8M |
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | 116.9% | ||
| Q3 25 | -11.4% | 40.2% | ||
| Q2 25 | -22.5% | 27.2% | ||
| Q1 25 | -27.2% | 23.1% | ||
| Q4 24 | -49.2% | 104.8% | ||
| Q3 24 | -32.6% | 27.6% | ||
| Q2 24 | -31.4% | 31.5% |
| Q1 26 | — | — | ||
| Q4 25 | 2.4% | 4.9% | ||
| Q3 25 | 3.4% | 1.7% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.7% | 1.7% | ||
| Q4 24 | 1.7% | 4.5% | ||
| Q3 24 | 0.4% | 1.3% | ||
| Q2 24 | 2.0% | 1.0% |
| Q1 26 | — | — | ||
| Q4 25 | — | 3.96× | ||
| Q3 25 | — | 1.33× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.93× | ||
| Q4 24 | — | 3.78× | ||
| Q3 24 | — | 0.98× | ||
| Q2 24 | — | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
TCBK
Segment breakdown not available.
